Measles and rubella

Measles is a highly infectious virus, and globally still one of the leading causes of childhood mortality. Rubella is usually mild when experienced in childhood, but it can often lead to serious and sometimes fatal complications in the foetus when an unprotected woman acquires the infection early in pregnancy. All countries in the WHO European Region include highly effective and safe measles- and rubella-containing vaccines in their routine immunization programmes.

European Vaccine Action Plan

Top story

WHO urges investments to stop measles transmission in Europe

The first-ever WHO Strategic Response Plan (SRP) for a measles emergency was launched today to ensure financial commitment to stop the spread of this highly contagious and serious disease in the WHO European Region.

Key resources

  • CISID

    WHO/Europe infectious disease data set, compiled from reports submitted by Member States

  • Measles and rubella laboratory data management system

    Information and resources for the Regional Measles and Rubella Lab Network

  • Immunization Resource Centre

    Documents designed to assist health professionals in their day-to-day work as it relates to immunization

  • WHO EpiBrief

    Periodical report containing an overview and analysis of epidemiological data on selected vaccine-preventable diseases in the WHO European Region.

  • WHO EpiData

    Monthly surveillance data by country presented in summary tables.

Vaccine safety communication library

Guidance on how to communicate about safety

European Immunization Week

Each year in April, EIW promotes the core message that the immunization of every child is vital to prevent diseases and protect life. The goal of the region-wide campaign is to increase vaccination coverage by raising awareness of the importance of immunization. EIW 2019 took place on 24-30 April 2019.

This year's campaign

WHO_Europe_VPI twitter feed